Homology Medicines (FIXX) PT Raised to $3.21 at Credit Suisse

August 16, 2022 3:26 AM EDT
Get Alerts FIXX Hot Sheet
Price: $1.43 --0%

Rating Summary:
    8 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 4 | Down: 12 | New: 14
Join SI Premium – FREE
Credit Suisse analyst Richard Law raised the price target on Homology Medicines (NASDAQ: FIXX) to $3.21 (from $3.10) while maintaining a Neutral rating.

You May Also Be Interested In

Related Categories

Analyst PT Change